首页 | 本学科首页   官方微博 | 高级检索  
检索        

基本药物目录遴选与使用的发展与创新
引用本文:李幼平,沈建通.基本药物目录遴选与使用的发展与创新[J].中国循证医学杂志,2013(11):1273-1279.
作者姓名:李幼平  沈建通
作者单位:四川大学华西医院中国循证医学中心,成都610041
摘    要:自1977年WHO发布第1版基本药物示范目录以来,基本药物目录(EML)已有36年历史,共发布了18版成人示范目录和4版儿童示范目录。1982年,我国发布了第l版EML,到2012年共发布了8版。本文介绍了WHO—EML的起源、理念、定义、设计,也介绍了WHO—EML遴选方法、原则、流程等方面的发展与创新,并与我国EML的沿革、设计、遴选方法进行对比,指出了我国EML评价与决策面临的挑战。

关 键 词:基本药物目录  使用  发展  创新

Application,Development and Innovation of Essential Medicine List
LI You-ping,SHEN Jian-tong.Application,Development and Innovation of Essential Medicine List[J].Chinese Journal of Evidence-based Medicine,2013(11):1273-1279.
Authors:LI You-ping  SHEN Jian-tong
Institution:Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China
Abstract:It has been 36 years since the first version of essential medicine list (EML) was released by WHO in 1977, when 18 versions of WHO-EML and four versions of children essential medicine list have been released. In 1982, the first version of national essential medicine list (NEML) was released in China. Till 2012, there were eight versions of NEML in total. This paper introduces WHO-EML in aspects of origin, idea, definition, design, and innovation of selection method- ology, principle, and workflow; compares the evolution, design, selection methodology between WHO-EML and Chinese NEML; and points out the challenges of evaluation and decision making of Chinese NEML.
Keywords:Essential Medicine List (EML)  Application  Development  Innovation
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号